ACI
MYOK

AMP Capital Investors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

AMP Capital Investors’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,432
Closed -$332K – 1326
2020
Q2 		$332K Buy
+3,432
New +$286K ﹤0.01% 1007

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

AMP Capital Investors's MYOK Position: Q3 2020 in Review

AMP Capital Investors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 3,432 shares — an estimated $332K sold.

AMP Capital Investors first reported a position in MYOK in Q2 2020 and held it in 1 quarter. The position peaked at $332K in Q2 2020. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

  • AMP Capital Investors reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • AMP Capital Investors sold 3,432 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $332K.
  • AMP Capital Investors first reported a position in MyoKardia, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • AMP Capital Investors's MyoKardia, Inc. Common Stock position peaked at $332K in Q2 2020.
  • 237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on AMP Capital Investors's 13F filing for Q3 2020, filed 12 Nov 2020.